NIH-funded research R01 grant

How red blood cell transfusions affect brain inflammation and development in anemic newborns

Official title: RBC transfusion exacerbates brain inflammation in anemic murine neonates and causes long term neurodevelopment impairment

Funded at University of Nebraska Medical Center · NIH-11029304 · Data updated 2026-11-12

This study looks at how blood transfusions for anemic newborns might affect their brain health and development, helping us find ways to reduce any negative effects while treating their anemia.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Nebraska Medical Center
NIH-funded
Lab location1 site (Omaha, United States)
Project startDecember 18, 2024
Project endNovember 30, 2029
Funding year2025
Award (this year)$415,832
NIH project number1R01HD116950-01
Project IDNIH-11029304 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are premature infants or critically ill newborns who require red blood cell transfusions due to severe anemia.

Less likely to help

Patients who are not newborns or do not require red blood cell transfusions for anemia may not benefit from this research.

What this research studies

This research investigates the impact of red blood cell transfusions on brain inflammation and neurodevelopment in anemic newborns. It focuses on understanding how these transfusions, while necessary for treating severe anemia, may inadvertently lead to brain inflammation and long-term cognitive impairments. The study employs a preclinical murine model to explore the mechanisms linking anemia, transfusions, and neurodevelopmental outcomes, aiming to identify potential therapeutic strategies to mitigate these adverse effects.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment protocols that minimize brain inflammation and enhance neurodevelopment in anemic newborns receiving transfusions.

How similar studies have gone: Previous studies have indicated a connection between red blood cell transfusions and neurodevelopmental impairments, suggesting that this research builds on established findings rather than exploring a completely novel approach.

Where this research is happening

  • University of Nebraska Medical Center
    Omaha, United States
    Active

Researchers

  • Principal investigator: Krishnan, Mohan Kumar — University of Nebraska Medical Center
  • Study coordinator: Krishnan, Mohan Kumar

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.